<?xml version="1.0" encoding="UTF-8"?>
<cgMDR:Data_Element xmlns:cgMDR="http://www.cancergrid.org/schema/cgMDR" item_registration_authority_identifier="GB-CANCERGRID" data_identifier="D1E679521" version="0.12">
    <cgMDR:administered_item_administration_record>
        <cgMDR:administrative_note>Auto generated during protege import</cgMDR:administrative_note>
        <cgMDR:administrative_status>noPendingChanges</cgMDR:administrative_status>
        <cgMDR:change_description>please complete change-description...</cgMDR:change_description>
        <cgMDR:creation_date>2006-08-08</cgMDR:creation_date>
        <cgMDR:effective_date>2006-08-08</cgMDR:effective_date>
        <cgMDR:explanatory_comment>please complete explanatory-comment...</cgMDR:explanatory_comment>
        <cgMDR:last_change_date>2006-12-12</cgMDR:last_change_date>
        <cgMDR:until_date>2006-12-12</cgMDR:until_date>
        <cgMDR:origin/>
        <cgMDR:registration_status>Superseded</cgMDR:registration_status>
        <cgMDR:unresolved_issue>please complete unresolved-issue...</cgMDR:unresolved_issue>
    </cgMDR:administered_item_administration_record>
    <cgMDR:administered_by>GB-CANCERGRID-000005-1</cgMDR:administered_by>
    <cgMDR:registered_by>GB-CANCERGRID-000009-1</cgMDR:registered_by>
    <cgMDR:submitted_by>GB-CANCERGRID-000006-1</cgMDR:submitted_by>
    <cgMDR:described_by>KNCSJG1HE</cgMDR:described_by>
    <cgMDR:classified_by>http://www.cancergrid.org/ontologies/data-element-classification#D1E13860</cgMDR:classified_by>
    <cgMDR:having>
        <cgMDR:context_identifier>GB-CANCERGRID-000001-1</cgMDR:context_identifier>
        <cgMDR:containing>
            <cgMDR:language_section_language_identifier>
                <cgMDR:country_identifier>GB</cgMDR:country_identifier>
                <cgMDR:language_identifier>eng</cgMDR:language_identifier>
            </cgMDR:language_section_language_identifier>
            <cgMDR:name>Oestrogen receptor status</cgMDR:name>
            <cgMDR:definition_text>as preferred</cgMDR:definition_text>
            <cgMDR:preferred_designation>false</cgMDR:preferred_designation>
            <cgMDR:definition_source_reference/>
        </cgMDR:containing>
    </cgMDR:having>
    <cgMDR:having>
        <cgMDR:context_identifier>GB-CANCERGRID-000001-1</cgMDR:context_identifier>
        <cgMDR:containing>
            <cgMDR:language_section_language_identifier>
                <cgMDR:country_identifier>GB</cgMDR:country_identifier>
                <cgMDR:language_identifier>eng</cgMDR:language_identifier>
            </cgMDR:language_section_language_identifier>
            <cgMDR:name>ER Status</cgMDR:name>
            <cgMDR:definition_text>An enumerated measurement based upon the quantity of oestrogen receptor per milligram of cytosol protein.  Values of 3-10 fmol are typically regarded as positive.  The Early Breast Cancer Trialist's Collaborative group cites 10fmol/mg.</cgMDR:definition_text>
            <cgMDR:preferred_designation>true</cgMDR:preferred_designation>
            <cgMDR:definition_source_reference/>
        </cgMDR:containing>
    </cgMDR:having>
    <cgMDR:data_element_precision>0</cgMDR:data_element_precision>
    <cgMDR:representation_class_qualifier/>
    <cgMDR:representing>GB-CANCERGRID-D1E679524-0.1</cgMDR:representing>
    <cgMDR:typed_by>GB-CANCERGRID-000010-1</cgMDR:typed_by>
    <cgMDR:expressing>GB-CANCERGRID-D1E679522-0.13</cgMDR:expressing>
    <cgMDR:exemplified_by>
        <cgMDR:data_element_example_item >please complete example...</cgMDR:data_element_example_item>
    </cgMDR:exemplified_by>
    <cgMDR:field_name preferred=""/>
    <cgMDR:question_text preferred=""/>
</cgMDR:Data_Element>